Journal of Antimicrobial Chemotherapy, Vol 41, 127-130, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy
CJ Clancy and MH Nguyen
We investigated the interaction between amphotericin B and azithromycin in
vitro against 26 clinical isolates of Fusarium. Synergy was demonstrated in
all isolates. Amphotericin B MICs were reduced from a mean of 1 mg/L when
tested alone to a mean of 0.37 mg/L when tested in combination with
azithromycin. Azithromycin demonstrated no activity against Fusarium when
tested alone (MIC > 128 mg/L). When combined with amphotericin B the
mean MIC was reduced to 5.5 mg/L, a level readily achieved in tissue. Given
the resistance of Fusarium to conventional therapy, the in-vitro synergy
between amphotericin B and azithromycin might prove to be important in
therapy for fusariosis.
ORIGINAL ARTICLES
The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis
Department of Medicine, University of Florida College of Medicine, Gainesville 32610, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Cuenca-Estrella Combinations of antifungal agents in therapy-what value are they? J. Antimicrob. Chemother., November 1, 2004; 54(5): 854 - 869. [Abstract] [Full Text] [PDF] |
||||
